Parkside Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,000
| Closed | -$509K | – | 93 |
|
|
2024
Q4 | $509K | Sell |
9,000
-9,000
| -50% | -$509K | 0.08% | 78 |
|
|
2024
Q3 | $931K | Buy |
+18,000
| New | +$931K | 0.14% | 64 |
|
|
2022
Q3 | – | Sell |
-66,188
| Closed | -$5.1M | – | 86 |
|
|
2022
Q2 | $5.1M | Sell |
66,188
-27,967
| -30% | -$2.15M | 1.07% | 39 |
|
|
2022
Q1 | $6.88M | Sell |
94,155
-30,894
| -25% | -$2.26M | 1.35% | 29 |
|
|
2021
Q4 | $7.8M | Buy |
125,049
+12,984
| +12% | +$809K | 1.5% | 21 |
|
|
2021
Q3 | $6.63M | Sell |
112,065
-1,521
| -1% | -$90K | 1.39% | 24 |
|
|
2021
Q2 | $7.59M | Buy |
113,586
+933
| +0.8% | +$62.3K | 1.46% | 20 |
|
|
2021
Q1 | $7.11M | Buy |
112,653
+22,633
| +25% | +$1.43M | 1.48% | 22 |
|
|
2020
Q4 | $5.58M | Buy |
90,020
+10,358
| +13% | +$642K | 1.24% | 31 |
|
|
2020
Q3 | $4.8M | Sell |
79,662
-442
| -0.6% | -$26.6K | 1.26% | 29 |
|
|
2020
Q2 | $4.71M | Sell |
80,104
-2,075
| -3% | -$122K | 1.25% | 24 |
|
|
2020
Q1 | $4.58M | Sell |
82,179
-16,125
| -16% | -$899K | 1.51% | 20 |
|
|
2019
Q4 | $6.31M | Buy |
98,304
+1,975
| +2% | +$127K | 1.53% | 17 |
|
|
2019
Q3 | $4.89M | Buy |
96,329
+7,250
| +8% | +$368K | 1.31% | 23 |
|
|
2019
Q2 | $7.46M | Buy |
89,079
+80,075
| +889% | +$6.71M | 1.94% | 10 |
|
|
2019
Q1 | $429K | Buy |
9,004
+4,000
| +80% | +$191K | 0.12% | 94 |
|
|
2018
Q4 | $260K | Sell |
5,004
-2,996
| -37% | -$156K | 0.11% | 102 |
|
|
2018
Q3 | $496K | Buy |
8,000
+2,600
| +48% | +$161K | 0.23% | 71 |
|
|
2018
Q2 | $299K | Sell |
5,400
-6,100
| -53% | -$338K | 0.15% | 82 |
|
|
2018
Q1 | $727K | Buy |
11,500
+8,500
| +283% | +$537K | 0.38% | 59 |
|
|
2017
Q4 | $184K | Buy |
+3,000
| New | +$184K | 0.09% | 96 |
|